Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL25422186 | 0.90 | TDP1 (0.45) | TDP1MAPK1MAPTLMNAHSD17B10 | |
| Propionic Acid SCHEMBL181620 | 0.88 | TDP1 (0.46) | TDP1MAPK1MAPTLMNAHSD17B10 | |
| Propionic Acid SCHEMBL1464843 | 0.88 | TDP1 (0.46) | TDP1MAPK1MAPTLMNAHSD17B10 | |
| Oxalic Acid SCHEMBL28567859 | 0.88 | TDP1 (0.44) | TDP1MAPK1MAPTLMNAHSD17B10 | |
| Acetic Acid SCHEMBL25433340 | 0.88 | TDP1 (0.44) | TDP1MAPK1MAPTLMNAHSD17B10 | |
| Acetic Acid SCHEMBL36448 | 0.88 | TDP1 (0.44) | TDP1MAPK1MAPTLMNAHSD17B10 | |
| Acetic Acid SCHEMBL8843133 | 0.88 | TDP1 (0.44) | TDP1MAPK1MAPTLMNAHSD17B10 | |
| SCHEMBL9581259 | 0.86 | TDP1 (0.42) | TDP1MAPK1MAPTLMNAHSD17B10 | |
| SCHEMBL9152798 | 0.86 | TDP1 (0.42) | TDP1MAPK1MAPTLMNAHSD17B10 | |
| SCHEMBL23248659 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113322013-B | Co-extrusion synergistic transparent adhesive film and preparation method thereof | 浙江祥邦科技股份有限公司 | 2022-10-04 | — | — | CN | claimed |
| CN-113322013-A | Co-extrusion synergistic transparent adhesive film and preparation method thereof | 浙江祥邦科技股份有限公司 | 2021-08-31 | — | — | CN | claimed |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| CN-113322013-B | Co-extrusion synergistic transparent adhesive film and preparation method thereof | 浙江祥邦科技股份有限公司 | 2022-10-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | TDP1 4632/4885MAPK1 3240/4885MAPT 4109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.